Evaluating AI Systems for Diabetic Retinopathy ...

By HEOR Staff Writer

August 15, 2024

Introduction Diabetes mellitus is a global health crisis affecting 1 in 10 adults. With rates quadrupling over the past two decades, approximately 537 million people are cur...
ABRE Study: Optimising Treatment for Iliofemoral Venous Obstruction
New Anti-Obesity Medications Should Be Considered Preventive Health Care
Modernising AI Medical Devices Regulation: FDA’s Firm-Based Approach
Addressing Valvular Heart Disease in Saudi Arabia
Innovative Funding Models for Non-Communicable Diseases
A New Approach to Cardiovascular Risk Assessment for Statin Therapy
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Cost Savings on Generic Drugs: Transparent Pricing Models
Advancing Cardiac Care: AI in Aortic Stenosis Management
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
The Relevance of AI in Mastering Polypharmacy Management
Advancing Healthcare: The Role of Real-World Evidence in Decision-Making